Literature DB >> 22391887

Physicochemical properties of amorphous roxithromycin prepared by quench cooling of the melt or desolvation of a chloroform solvate.

Marique Aucamp1, Wilna Liebenberg, Schalk J Strydom, Elsa C van Tonder, Melgardt M de Villiers.   

Abstract

Roxithromycin is a poorly soluble antibacterial drug. The aim of this study was to prepare and characterize an amorphous form of roxithromycin. The amorphous form was prepared by desolvation of its chloroform solvate, and by quench cooling a melt of the crystalline monohydrated solid. The X-ray powder diffraction pattern of the desolvated chloroform solvate was indistinguishable from that of the glass prepared by melting, which indicated that it was amorphous. The roxithromycin glass was determined to be a fragile glass, but due to its high Kauzmann temperature (approximately 8°C), it should remain fairly stable upon refrigeration or even at room temperature. It was also determined that this glass remains stable in the presence of moisture with no indication of crystallization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391887      PMCID: PMC3364397          DOI: 10.1208/s12249-012-9766-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  17 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Correlations of the nonexponentiality and state dependence of mechanical relaxations with bond connectivity in Ge-As-Se supercooled liquids.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1992-05-01

Review 3.  Basics and applications of solid-state kinetics: a pharmaceutical perspective.

Authors:  Ammar Khawam; Douglas R Flanagan
Journal:  J Pharm Sci       Date:  2006-03       Impact factor: 3.534

4.  Fragility and thermodynamics in nonpolymeric glass-forming liquids.

Authors:  Li-Min Wang; C Austen Angell; Ranko Richert
Journal:  J Chem Phys       Date:  2006-08-21       Impact factor: 3.488

5.  Glass fragility and the stability of pharmaceutical preparations--excipient selection.

Authors:  R H Hatley
Journal:  Pharm Dev Technol       Date:  1997-08       Impact factor: 3.133

Review 6.  Roxithromycin: review of its antimicrobial activity.

Authors:  A Bryskier
Journal:  J Antimicrob Chemother       Date:  1998-03       Impact factor: 5.790

7.  Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates.

Authors:  S Q Henwood; W Liebenberg; L R Tiedt; A P Lötter; M M de Villiers
Journal:  Drug Dev Ind Pharm       Date:  2001-11       Impact factor: 3.225

8.  In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine.

Authors:  Y Li; J Han; G G Zhang; D J Grant; R Suryanarayanan
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

9.  Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.

Authors:  V Naini; P R Byron; E M Phillips
Journal:  Drug Dev Ind Pharm       Date:  1998-10       Impact factor: 3.225

10.  The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine.

Authors:  Schalk Strydom; Wilna Liebenberg; Lian Yu; Melgardt de Villiers
Journal:  Int J Pharm       Date:  2009-06-18       Impact factor: 5.875

View more
  1 in total

1.  The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.

Authors:  Marnus Milne; Wilna Liebenberg; Marique Aucamp
Journal:  AAPS PharmSciTech       Date:  2015-03-04       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.